Depth of response and progression-free survival in patients with advanced <i>ALK</i>-positive non-small-cell lung cancer treated with lorlatinib.

Campelo R. G., Schulz C., Min Y. J., AYDINER A., Hussein M. A., di Pietro A., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 30 May - 03 June 2025, vol.43, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 43
• Doi Number: 10.1200/jco.2025.43.16_suppl.8589
• City: Illinois
• Country: United States Of America
• Istanbul University Affiliated: Yes